Michael B. Hoffman - 07 Jul 2021 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director, 10%+ Owner
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Michael Hoffman
Issuer symbol
ANVS
Transactions as of
07 Jul 2021
Net transactions value
$0
Form type
4
Filing time
09 Jul 2021, 18:26:25 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +4,500 $0.000000 4,500 07 Jul 2021 Common Stock 4,500 $102.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date.